ATE349550T1 - Reihentestverfahren auf moleküle mit anti- prionaktivität: kits, methoden und moleküle - Google Patents
Reihentestverfahren auf moleküle mit anti- prionaktivität: kits, methoden und moleküleInfo
- Publication number
- ATE349550T1 ATE349550T1 AT03778411T AT03778411T ATE349550T1 AT E349550 T1 ATE349550 T1 AT E349550T1 AT 03778411 T AT03778411 T AT 03778411T AT 03778411 T AT03778411 T AT 03778411T AT E349550 T1 ATE349550 T1 AT E349550T1
- Authority
- AT
- Austria
- Prior art keywords
- molecules
- kits
- methods
- antiprion
- activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0213022A FR2846008B1 (fr) | 2002-10-18 | 2002-10-18 | Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees |
| FR0308289A FR2846009B1 (fr) | 2002-10-18 | 2003-07-07 | Criblage de molecules a activite anti-prion:kits, methodes et molecules criblees |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE349550T1 true ATE349550T1 (de) | 2007-01-15 |
Family
ID=32071174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03778411T ATE349550T1 (de) | 2002-10-18 | 2003-10-20 | Reihentestverfahren auf moleküle mit anti- prionaktivität: kits, methoden und moleküle |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US8129402B2 (de) |
| EP (1) | EP1551992B1 (de) |
| JP (1) | JP4529030B2 (de) |
| AT (1) | ATE349550T1 (de) |
| AU (1) | AU2003285413A1 (de) |
| CA (1) | CA2502544C (de) |
| DE (1) | DE60310744T2 (de) |
| ES (1) | ES2279975T3 (de) |
| FR (1) | FR2846009B1 (de) |
| WO (1) | WO2004035813A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602006006578D1 (de) * | 2006-10-04 | 2009-06-10 | Agronomique Inst Nat Rech | Chlor enthaltende Guanabenz Derivate zur Behandlung von Prionerkrankungen |
| CN101481729B (zh) * | 2009-01-21 | 2014-04-16 | 辽宁大学 | 一种高灵敏度的利用基因突变酵母细胞筛选抗朊病毒药物的方法 |
| WO2018073321A1 (en) | 2016-10-18 | 2018-04-26 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Natural product derivatives for inhibiting cellular necroptosis, ferroptosis and oxytosis |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3758479A (en) * | 1967-03-22 | 1973-09-11 | Sandoz Ag | Nitro and sulphamoyl substituted dibenzodiazepines |
| DE2430380C3 (de) * | 1974-06-25 | 1980-04-30 | Behringwerke Ag, 3550 Marburg | Herstellung eines Stoffes mit immunologischer Wirkung |
| JPH0262826A (ja) * | 1988-08-30 | 1990-03-02 | Sawai Seiyaku Kk | 成人ｔ細胞白血病治療剤 |
| EP0565491A1 (de) * | 1992-04-10 | 1993-10-13 | Dornag Ag | Kupplungsvorrichtung, insbesondere zur Kupplung eines Werkzeughalters mit einer Antriebswelle |
| US5472714A (en) * | 1993-09-08 | 1995-12-05 | Ciba-Geigy Corporation | Double-layered oxcarbazepine tablets |
| US7799535B1 (en) * | 1997-12-09 | 2010-09-21 | Arch Development Corporation | Methods for identifying factors that control the folding of amyloid proteins of diverse origin |
| WO2000019964A2 (en) * | 1998-10-08 | 2000-04-13 | New Ace Research Company | Novel compositions and methods for prevention and treatment of protozoal disease |
| US6200771B1 (en) * | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
| US6479504B1 (en) * | 1999-06-16 | 2002-11-12 | The University Of Iowa Research Foundation | Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases |
| ATE532874T1 (de) * | 2001-02-15 | 2011-11-15 | Univ Chicago | Verfahren zum nachweis in hefe für mittels die proteinfaltung beeinflussen |
-
2003
- 2003-07-07 FR FR0308289A patent/FR2846009B1/fr not_active Expired - Fee Related
- 2003-10-20 WO PCT/FR2003/003101 patent/WO2004035813A2/fr active IP Right Grant
- 2003-10-20 AT AT03778411T patent/ATE349550T1/de not_active IP Right Cessation
- 2003-10-20 JP JP2005501302A patent/JP4529030B2/ja not_active Expired - Fee Related
- 2003-10-20 AU AU2003285413A patent/AU2003285413A1/en not_active Abandoned
- 2003-10-20 CA CA2502544A patent/CA2502544C/fr not_active Expired - Fee Related
- 2003-10-20 ES ES03778411T patent/ES2279975T3/es not_active Expired - Lifetime
- 2003-10-20 DE DE60310744T patent/DE60310744T2/de not_active Expired - Lifetime
- 2003-10-20 US US10/531,594 patent/US8129402B2/en not_active Expired - Fee Related
- 2003-10-20 EP EP03778411A patent/EP1551992B1/de not_active Expired - Lifetime
-
2006
- 2006-07-11 US US11/483,822 patent/US20070031821A1/en not_active Abandoned
-
2010
- 2010-08-17 US US12/858,235 patent/US20110092483A1/en not_active Abandoned
-
2011
- 2011-12-16 US US13/328,611 patent/US20120122916A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2502544C (fr) | 2012-11-20 |
| FR2846009B1 (fr) | 2007-10-12 |
| WO2004035813A3 (fr) | 2004-07-15 |
| AU2003285413A1 (en) | 2004-05-04 |
| AU2003285413A8 (en) | 2004-05-04 |
| CA2502544A1 (fr) | 2004-04-29 |
| US20070031821A1 (en) | 2007-02-08 |
| US20120122916A1 (en) | 2012-05-17 |
| EP1551992B1 (de) | 2006-12-27 |
| JP4529030B2 (ja) | 2010-08-25 |
| US20110092483A1 (en) | 2011-04-21 |
| DE60310744D1 (de) | 2007-02-08 |
| US20060172337A1 (en) | 2006-08-03 |
| EP1551992A2 (de) | 2005-07-13 |
| WO2004035813A2 (fr) | 2004-04-29 |
| ES2279975T3 (es) | 2007-09-01 |
| JP2006502745A (ja) | 2006-01-26 |
| US8129402B2 (en) | 2012-03-06 |
| DE60310744T2 (de) | 2007-10-11 |
| FR2846009A1 (fr) | 2004-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1242822T3 (da) | Fremgangsmåder til påvisning af amyloidogene proteiner | |
| DE69726306D1 (de) | Renilla luciferase und green fluorescent protein fusionsgene | |
| CY1108630T1 (el) | Εξεταση βιοισοδυναμιας δια συνθεσεις οι οποιες περιεχουν σιδηρο | |
| ATE517638T1 (de) | Verfahren und zubereitungen zum verabreichen von therapeutischen und diagnostischen mitteln | |
| NO20075077L (no) | Fremgangsmate for a forbedre laering og hukommelse i pattedyr | |
| DE602005016800D1 (de) | Hif-prolylhydroxylase-aktivitätstest | |
| DE60321552D1 (de) | Neues verfahren für die diagnose und prognose von malignen erkrankungen | |
| NO20062118L (no) | Inhibitor kontrastmidler | |
| NO20081362L (no) | System og fremgangsmate for a gi en sammensatt maling av en blanding som har innblandet gass | |
| DE60310583D1 (de) | Verfahren zum nachweis von methicillinresistenten staphylococcus aureus | |
| ATE349550T1 (de) | Reihentestverfahren auf moleküle mit anti- prionaktivität: kits, methoden und moleküle | |
| Inamullah et al. | Teacher-Student Verbal Interaction Patterns at the Tertiary Level of Education. | |
| WO2007054537A8 (en) | Novel bacterium and vaccine | |
| Ghesquière et al. | Spatiotemporal monitoring of a periodontal multispecies biofilm model: demonstration of prebiotic treatment responses | |
| FR2894594B1 (fr) | Test predictif de reponse therapeutique du cancer du sein | |
| WO2005046581A3 (en) | P18 in stem cell manipulations | |
| WO2010006616A3 (en) | Method and kit for examination of cells using n-(9-acridinyl)maleimide (nam) or using 7-diethylamino-3-((4'-(iodoacetyl)amino)phenyl)-4-methylcoumarin (cpi) | |
| Lee et al. | Characterization of Lung Endothelial Cell Heterogeneity in Idiopathic Pulmonary Fibrosis (IPF) | |
| Mijatović et al. | Trait emotional intelligence as a predictor of loneliness during the covid-19 pandemic | |
| 小林平造 et al. | Z4 Repository | |
| Withers et al. | 40. Correlation Between OSCEs and Dental Hygiene Clinic Grades | |
| ATE420361T1 (de) | Marker für therapie mit antidepressiva und damit in zusammenhang stehende verfahren | |
| ATE354669T1 (de) | Verfahren für das selektive überleben oder wachstum von zielzellen mittels der verwendung eines konjugats sowie deren verwendung in therapie und diagnose | |
| BRPI0417461A (pt) | testes de suscetibilidade estabilizados de patógenos aeróbicos | |
| MX2008013437A (es) | Metodo para administrar tolperisona. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |